Citations

Citations to this article as recorded by  

• Genetic Determinants of Hematopoietic Toxicity Risk in Thai Pediatric Patients Undergoing 6‐Mercaptopurine Treatment
  Kanyarat Khaeso, Su‐on Chainansamit, Pitchayanan Kuwatjanakul, Patcharee Komvilaisak, Nontaya Nakkam, Kunanya Suwannaying, Suda Vannaprasaht, Areerat Dornsena, Wichittra Tassaneeyakul
  Clinical and Translational Science.2026;[Epub]     CrossRef
• Monogenic forms of inflammatory bowel disease: Genetic mechanisms, models, and clinical implications
  Amirhossein Ghorbanpour, Pejman Rohani, Shabnam Shahrokh, Georges Dimitrov, Mehdi Totonchi, Stefan Dimitrov
  Molecular Medicine.2026;[Epub]     CrossRef
• Comprehensive overview of the global pharmacogenetic and functional variability in NUDT15
  Yitian Zhou, Lukas M. Lauschke, Volker M. Lauschke
  Human Genomics.2026;[Epub]     CrossRef
• A case of rapidly progressive hair loss due to azathioprine, and the prevalence of NUDT15 variants among Japanese patients with autoimmune blistering diseases: A single‐center retrospective observational study
  Sho Katayama, Kentaro Izumi, Inkin Ujiie, Hideyuki Ujiie
  The Journal of Dermatology.2025; 52(2): 363.     CrossRef
• Comparative study on the pathogenesis of Crohn’s disease and ulcerative colitis
  Qi-Hang Yang, Chuang-Nian Zhang
  World Journal of Gastroenterology.2025;[Epub]     CrossRef
• Establishment of a novel predictive model for thiopurine-induced leucopenia based on the polymorphisms in the DNA-thioguanine nucleotide metabolite pathway in Chinese patients with inflammatory bowel disease
  Xia Zhu, Xue-ding Wang, Qiao-lan Xuan, Shao-xing Guan, Yan-pin Guan, Xiang Gao, Kang Chao, Min Huang
  Drug Metabolism and Disposition.2025; 53(8): 100119.     CrossRef
• Real-world NUDT15 genotyping and thiopurine treatment optimization in inflammatory bowel disease: a multicenter study
  Motoki Makuuchi, Yoichi Kakuta, Junji Umeno, Toshimitsu Fujii, Tetsuya Takagawa, Takashi Ibuka, Miki Miura, Yu Sasaki, Sakuma Takahashi, Hiroshi Nakase, Hiroki Kiyohara, Keiichi Tominaga, Yosuke Shimodaira, Sakiko Hiraoka, Nobuhiro Ueno, Shunichi Yanai, T
  Journal of Gastroenterology.2024; 59(6): 468.     CrossRef
• Differences in the risk of clinical failure between thiopurine and methotrexate in bio-naïve patients with Crohn’s disease: a Korean nationwide population-based study
  Yu Kyung Jun, Eunjeong Ji, Hye Ran Yang, Yonghoon Choi, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee, Hyuk Yoon
  Therapeutic Advances in Gastroenterology.2024;[Epub]     CrossRef
• A systematic review of aspects of NUDT15 pharmacogenomic variants and thiopurine-induced myelosuppression
  Rachel Palmer, Jaime Peters
  RPS Pharmacy and Pharmacology Reports.2024;[Epub]     CrossRef
• m6A modification in inflammatory bowel disease provides new insights into clinical applications
  Jiamin Zhang, Bimei Song, Yue Zeng, Chao Xu, Liang Gao, Yan Guo, Jingbo Liu
  Biomedicine & Pharmacotherapy.2023; 159: 114298.     CrossRef
• Targeting FTO by Dac51 contributes to attenuating DSS-induced colitis
  Chunyan Peng, Chang Zheng, Fan Zhou, Ying Xie, Lei Wang, Deyan Chen, Xiaoqi Zhang
  International Immunopharmacology.2023; 116: 109789.     CrossRef
• Single-Nucleotide Polymorphisms, c.415C > T (Arg139Cys) and c.416G > A (Arg139His), in the NUDT15 Gene Are Associated with Thiopurine-Induced Leukopenia
  Tetsuichiro Isono, Daiki Hira, Yoshito Ikeda, Masahiro Kawahara, Satoshi Noda, Atsushi Nishida, Osamu Inatomi, Noriki Fujimoto, Akira Andoh, Tomohiro Terada, Shin-ya Morita
  Biological and Pharmaceutical Bulletin.2023; 46(3): 412.     CrossRef
• Evaluation of FTO polymorphism in 6-mercaptopurine related intolerance in children with acute lymphoblastic leukemia
  Minu Singh, Divya Bhaskar, Prateek Bhatia, Rozy Thakur, Pankaj Sharma, Deepak Bansal, Richa Jain, Amita Trehan
  Cancer Chemotherapy and Pharmacology.2023; 92(1): 51.     CrossRef
• Time to incorporate preemptive NUDT15 testing before starting thiopurines in inflammatory bowel disease in Asia and beyond: a review
  Devendra Desai, Anuraag Jena, Vishal Sharma, Toshifumi Hibi
  Expert Review of Clinical Pharmacology.2023; 16(7): 643.     CrossRef
• Safety and efficacy of personalized versus standard initial dosing of thiopurines: Systematic review and meta-analysis of randomized trials
  Anuraag Jena, Chhagan L Birda, Arup Choudhury, Vishal Sharma
  Expert Opinion on Drug Safety.2023; 22(12): 1253.     CrossRef
• Comparative assessment of anti-cancer drugs against NUDT15 variants to prevent leucopenia side effect in leukemia patients
  V. Janakiraman, M. Sudhan, Khalaf F. Alsharif, Ibrahim F. Halawani, Shiek S.S.J. Ahmed, Shankargouda Patil
  Journal of Genetic Engineering and Biotechnology.2023; 21(1): 82.     CrossRef
• A rare case of Azathioprine-induced leukopenia in an European woman
  Wautier Séverine, De Koninck Xavier, Coche Jean-Charles
  Acta Clinica Belgica.2022; 77(1): 163.     CrossRef
• NUDT15 is a key genetic factor for prediction of hematotoxicity in pediatric patients who received a standard low dosage regimen of 6-mercaptopurine
  Kanyarat Khaeso, Patcharee Komvilaisak, Su-on Chainansamit, Nontaya Nakkam, Kunanya Suwannaying, Pitchayanan Kuwatjanakul, Keiko Hikino, Areerat Dornsena, Sirimas Kanjanawart, Napat Laoaroon, Suda Vannaprasaht, Takeshi Taketani, Wichittra Tassaneeyakul
  Drug Metabolism and Pharmacokinetics.2022; 43: 100436.     CrossRef
• Nudix Hydroxylase 15 Mutations Strongly Predict Thiopurine-Induced Leukopenia Across Different Asian Ethnicities: Implications for Screening in a Diverse Population
  Xin-Hui Khoo, Shin Yee Wong, Nik Razima Wan Ibrahim, Ruey Terng Ng, Kee Seang Chew, Way Seah Lee, Zhi Qin Wong, Raja Affend Raja Ali, Shahreedhan Shahrani, Alex Hwong-Ruey Leow, Ida Normiha Hilmi
  Frontiers in Medicine.2022;[Epub]     CrossRef
• NUDT15Genotyping in Thiopurine Drug Therapy
  Jong Kwon Lee, Rihwa Choi, Soo-Youn Lee
  Laboratory Medicine Online.2022; 12(4): 217.     CrossRef
• Personalized medicine to implementation science: Thiopurines set for the leap
  Vishal Sharma, Saurabh Kedia, Vineet Ahuja
  JGH Open.2022; 6(10): 651.     CrossRef
• Pharmacogenetic determinants of thiopurines in an Indian cohort
  Shaik Mohammad Naushad, Mekala Janaki Ramaiah, Vijay Kumar Kutala, Tajamul Hussain, Salman A. Alrokayan
  Pharmacological Reports.2021; 73(1): 278.     CrossRef
• The Emerging Clinical Application of m6A RNA Modification in Inflammatory Bowel Disease and Its Associated Colorectal Cancer
  Xinwei Xu, Jintu Huang, Dickson Kofi Wiredu Ocansey, Yuxuan Xia, Zihan Zhao, Zhiwei Xu, Yongmin Yan, Xu Zhang, Fei Mao
  Journal of Inflammation Research.2021; Volume 14: 3289.     CrossRef
• Importance of NUDT15 Polymorphisms in Thiopurine Treatments
  Yoichi Tanaka, Yoshiro Saito
  Journal of Personalized Medicine.2021; 11(8): 778.     CrossRef
• Randomised clinical trial: dose optimising strategy by NUDT15 genotyping reduces leucopenia during thiopurine treatment of Crohn's disease
  Kang Chao, Yibiao Huang, Xia Zhu, Jian Tang, Xueding Wang, Lang Lin, Huili Guo, Caibin Zhang, Miao Li, Qingfan Yang, Jie Huang, Lingna Ye, Pinjin Hu, Min Huang, Qian Cao, Xiang Gao
  Alimentary Pharmacology & Therapeutics.2021; 54(9): 1124.     CrossRef
• Meta-Analysis of NUDT15 Genetic Polymorphism on Thiopurine-Induced Myelosuppression in Asian Populations
  Kanyarat Khaeso, Sariya Udayachalerm, Patcharee Komvilaisak, Su-on Chainansamit, Kunanya Suwannaying, Napat Laoaroon, Pitchayanan Kuwatjanakul, Nontaya Nakkam, Chonlaphat Sukasem, Apichaya Puangpetch, Wichittra Tassaneeyakul, Nathorn Chaiyakunapruk
  Frontiers in Pharmacology.2021;[Epub]     CrossRef
• High-resolution melt analysis enables simple genotyping of complicated polymorphisms of codon 18 rendering the NUDT15 diplotype
  Yoichi Kakuta, Yasuhiro Izumiyama, Daisuke Okamoto, Takeru Nakano, Ryo Ichikawa, Takeo Naito, Rintaro Moroi, Masatake Kuroha, Yoshitake Kanazawa, Tomoya Kimura, Hisashi Shiga, Hisaaki Kudo, Naoko Minegishi, Yosuke Kawai, Katsushi Tokunaga, Masao Nagasaki,
  Journal of Gastroenterology.2020; 55(1): 67.     CrossRef
• An intronic FTO variant rs16952570 confers protection against thiopurine-induced myelotoxicities in multiethnic Asian IBD patients
  Sylvia Chen, Wei Zhi Tan, Natalia Sutiman, Cindy Lim, Sze Sing Lee, Wai Fook Leong, Madeline Tjai, Chunyan Wang, Chris San Choon Kong, Sai Wei Chuah, Brian John Schwender, Webber Chan, Hang Hock Shim, Wee Chian Lim, Chiea Chuen Khor, Khoon Lin Ling, Balra
  The Pharmacogenomics Journal.2020; 20(3): 505.     CrossRef
• Precision therapy of 6‐mercaptopurine in Chinese children with acute lymphoblastic leukaemia
  Yue Zhou, Li Wang, Xiao‐Ying Zhai, Li Wen, Fang Tang, Fan Yang, Xi‐Ting Liu, Lei Dong, Li‐Juan Zhi, Hai‐Yan Shi, Guo‐Xiang Hao, Yi Zheng, Evelyne Jacqz‐Aigrain, Tian‐You Wang, Wei Zhao
  British Journal of Clinical Pharmacology.2020; 86(8): 1519.     CrossRef
• NUDT15 gene variants and thiopurine-induced leukopenia in patients with inflammatory bowel disease
  Katsuyoshi Matsuoka
  Intestinal Research.2020; 18(3): 275.     CrossRef
• Long‐term effect of NUDT15 R139C on hematologic indices in inflammatory bowel disease patients treated with thiopurine
  Shintaro Akiyama, Katsuyoshi Matsuoka, Kyoko Fukuda, Shunsuke Hamada, Mikiko Shimizu, Kosaku Nanki, Shinta Mizuno, Hiroki Kiyohara, Mari Arai, Shinya Sugimoto, Yasushi Iwao, Haruhiko Ogata, Tadakazu Hisamatsu, Makoto Naganuma, Maiko Motobayashi, Kohei Suz
  Journal of Gastroenterology and Hepatology.2019; 34(10): 1751.     CrossRef
• Systematic review with meta‐analysis: risk factors for thiopurine‐induced leukopenia in IBD
  Sara van Gennep, Kadère Konté, Berrie Meijer, Martijn W. Heymans, Geert R. D’Haens, Mark Löwenberg, Nanne K. H. de Boer
  Alimentary Pharmacology & Therapeutics.2019; 50(5): 484.     CrossRef
• Mycophenolate mofetil and prednisolone for cerebral sinus venous thrombosis with Behcet's disease
  Shintaro Terashita, Tomomi Tanaka, Hiromichi Taneichi, Yuichi Adachi, Masaaki Mori
  Pediatrics International.2019; 61(9): 920.     CrossRef
• Behcet's Disease With Cerebral Artery Infarction Caused by Cerebral Arteritis as an Early Symptom Only With Elevated Interleukin-8
  Hao Yin, Yun Song, Meimei Zheng, Ju Han, Jiyou Tang
  Frontiers in Neurology.2019;[Epub]     CrossRef
• Pharmacogenetics of thiopurines for inflammatory bowel disease in East Asia: prospects for clinical application of NUDT15 genotyping
  Yoichi Kakuta, Yoshitaka Kinouchi, Tooru Shimosegawa
  Journal of Gastroenterology.2018; 53(2): 172.     CrossRef
• NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study
  Yoichi Kakuta, Yosuke Kawai, Daisuke Okamoto, Tetsuya Takagawa, Kentaro Ikeya, Hirotake Sakuraba, Atsushi Nishida, Shoko Nakagawa, Miki Miura, Takahiko Toyonaga, Kei Onodera, Masaru Shinozaki, Yoh Ishiguro, Shinta Mizuno, Masahiro Takahara, Shunichi Yanai
  Journal of Gastroenterology.2018; 53(9): 1065.     CrossRef
• Severe thiopurine‐induced leukocytopenia and hair loss in Japanese patients with defective NUDT15 variant: Retrospective case–control study
  Mari Kishibe, Hiroyoshi Nozaki, Mizue Fujii, Shin Iinuma, Sawa Ohtsubo, Satomi Igawa, Kyoko Kanno, Masaru Honma, Kan Kishibe, Kensaku Okamoto, Akemi Ishida‐Yamamoto
  The Journal of Dermatology.2018; 45(10): 1160.     CrossRef
• Diagnostic accuracy of NUDT15 gene variants for thiopurine-induced leukopenia: a systematic review and meta-analysis
  Sarah Cargnin, Armando A. Genazzani, Pier Luigi Canonico, Salvatore Terrazzino
  Pharmacological Research.2018; 135: 102.     CrossRef
• A single‐center experience with methotrexate in the treatment of Chinese Crohn’s disease patients
  Tian Rong Wang, Yu Qi Qiao, Duo Wu Zou, Zhi Hua Ran
  Journal of Digestive Diseases.2018; 19(12): 753.     CrossRef

Citations

Citations to this article as recorded by  

• Safety of advanced therapies in pregnant women with inflammatory bowel disease: a systematic review and Meta-Analysis
  Bernardo de Faria Moraes, Gustavo André Pedral Diniz Leite, Luisa Medeiros Visentini, Gabriel André Pedral Diniz Leite, Igor Boechat Silveira, Valbert Oliveira Costa Filho, Luis Pedro Possapp Beis, Leonardo Corrêa Süffert, Pedro Robson Costa Passos, Guilh
  Journal of Crohn's and Colitis.2026;[Epub]     CrossRef
• Ulcerative Colitis in Pregnancy: A Japanese Multicenter Cohort Study Focusing on Their Mutual Influence
  Yuichi Shimodate, Akiko Shiotani, Ken-ichi Tarumi, Hiroshi Matsumoto, Osamu Handa, Noriaki Tomioka, Naoyuki Nishimura, Kazuhiro Matsueda, Hirokazu Mouri, Motowo Mizuno
  Internal Medicine.2025; 64(11): 1633.     CrossRef
• North American clinical practice guidelines for the medical management of hidradenitis suppurativa in special patient populations
  Raed Alhusayen, Serena Dienes, Megan Lam, Afsaneh Alavi, Ali Alikhan, Maria Aleshin, Emad Bahashwan, Steve Daveluy, Noah Goldfarb, Amit Garg, Wayne Gulliver, Tarannum Jaleel, Alexa B. Kimball, Mark G. Kirchhof, Joslyn Kirby, Joi Lenczowski, Hadar Lev-Tov,
  Journal of the American Academy of Dermatology.2025; 92(4): 825.     CrossRef
• A retrospective study of neonatal and pregnancy outcomes in pregnant women suffering from inflammatory arthropathy treated with adalimumab
  Navid Najarpour, Elham Rajaei, Karim Mowla, Alireza Ghanbaran
  Revista Colombiana de Reumatología.2024; 31(3): 290.     CrossRef
• Anti-tumor necrosis factor-α therapy may not be safe during pregnancy in women with inflammatory bowel disease: an updated meta-analysis and systematic review
  Wei Huang, Xinxing Zhang, Li Zhang, Xiaosong Dai, Heping Chen, Qin Xie
  BMC Pregnancy and Childbirth.2024;[Epub]     CrossRef
• A retrospective study of neonatal and pregnancy outcomes in pregnant women suffering from inflammatory arthropathy treated with adalimumab
  Navid Najarpour, Elham Rajaei, Karim Mowla, Alireza Ghanbaran
  Revista Colombiana de Reumatología (English Edition).2024; 31(3): 290.     CrossRef
• The treatment of inflammatory bowel disease with monoclonal antibodies in Asia
  Yu Chen, Guolin Zhang, Yuewen Yang, Shuangshuang Zhang, Haozheng Jiang, Kang Tian, Arenbaoligao, Dapeng Chen
  Biomedicine & Pharmacotherapy.2023; 157: 114081.     CrossRef
• Saudi consensus guidance for the management of inflammatory bowel disease during pregnancy
  Nahla A. Azzam, Abdulelah Almutairdi, Hajer Y. Almudaiheem, Turki AlAmeel, Shakir A. Bakkari, Othman R. Alharbi, Khalidah A. Alenzi, Maha A. AlMolaiki, Bedor A. Al-Omari, Rayan G. Albarakati, Ahmed H. Al-Jedai, Omar I. Saadah, Majid A. Almadi, Badr Al-Baw
  Saudi Journal of Gastroenterology.2023;[Epub]     CrossRef
• Biologics for Inflammatory Bowel Disease and Their Safety in Pregnancy: A Systematic Review and Meta-analysis
  Ole Haagen Nielsen, John Mark Gubatan, Carsten Bogh Juhl, Sarah Elizabeth Streett, Cynthia Maxwell
  Clinical Gastroenterology and Hepatology.2022; 20(1): 74.     CrossRef
• British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids
  Mark D Russell, Mrinalini Dey, Julia Flint, Philippa Davie, Alexander Allen, Amy Crossley, Margreta Frishman, Mary Gayed, Kenneth Hodson, Munther Khamashta, Louise Moore, Sonia Panchal, Madeleine Piper, Clare Reid, Katherine Saxby, Karen Schreiber, Naz Se
  Rheumatology.2022;[Epub]     CrossRef
• Association between Thiopurines Use and Pregnancy Outcomes in Female Patients with Inflammatory Bowel Disease: A Meta-Analysis
  Yang Zhang, Dandan Li, Heng Guo, Weina Wang, Xingang Li, Su Shen
  Current Pharmaceutical Design.2021; 27(19): 2317.     CrossRef
• Exposure to Infliximab During Pregnancy: Post-Marketing Experience
  Anja Geldhof, Jennifer Slater, Michael Clark, Urmila Chandran, Danielle Coppola
  Drug Safety.2020; 43(2): 147.     CrossRef
• The use of biological disease-modifying antirheumatic drugs for inflammatory arthritis in Korea: results of a Korean Expert Consensus
  Eun-Jung Park, Hyungjin Kim, Seung Min Jung, Yoon-Kyoung Sung, Han Joo Baek, Jisoo Lee
  The Korean Journal of Internal Medicine.2020; 35(1): 41.     CrossRef
• The Use of Biological Disease-modifying Antirheumatic Drugs for Inflammatory Arthritis in Korea: Results of a Korean Expert Consensus
  Eun-Jung Park, Hyungjin Kim, Seung Min Jung, Yoon-Kyoung Sung, Han Joo Baek, Jisoo Lee
  Journal of Rheumatic Diseases.2020; 27(1): 4.     CrossRef
• Maternal and neonatal outcomes associated with biologic exposure before and during pregnancy in women with inflammatory systemic diseases: a systematic review and meta-analysis of observational studies
  Nicole W Tsao, Nevena Rebic, Larry D Lynd, Mary A De Vera
  Rheumatology.2020; 59(8): 1808.     CrossRef
• Intrauterine Exposure to Biologics in Inflammatory Autoimmune Diseases: A Systematic Review
  N. Ghalandari, R. J. E. M. Dolhain, J. M. W. Hazes, E. P. van Puijenbroek, M. Kapur, H. J. M. J. Crijns
  Drugs.2020; 80(16): 1699.     CrossRef
• Pregnancy and Neuromyelitis Optica Spectrum Disorder – Reciprocal Effects and Practical Recommendations: A Systematic Review
  Rohan D'Souza, Danielle Wuebbolt, Katarina Andrejevic, Rizwana Ashraf, Vanessa Nguyen, Nusrat Zaffar, Dalia Rotstein, Ahraaz Wyne
  Frontiers in Neurology.2020;[Epub]     CrossRef
• Relationship between the Clinical Course of Ulcerative Colitis during Pregnancy and the Outcomes of Pregnancy: A Retrospective Evaluation
  Ayumi Ito, Bunei Iizuka, Teppei Omori, Shinichi Nakamura, Katsutoshi Tokushige
  Internal Medicine.2018; 57(2): 159.     CrossRef
• The use of biologics and small molecules in pregnant patients with rheumatic diseases
  Maria Gerosa, Lorenza Maria Argolini, Carolina Artusi, Cecilia Beatrice Chighizola
  Expert Review of Clinical Pharmacology.2018; 11(10): 987.     CrossRef
• Long-term clinical outcome after infliximab discontinuation in patients with inflammatory bowel disease
  Ji Min Lee, Yoon Jae Kim, Kang-Moon Lee, Hyuk Yoon, Bo-In Lee, Dae Bum Kim, Donghoon Kang
  Scandinavian Journal of Gastroenterology.2018; 53(10-11): 1280.     CrossRef
• Impact of inflammatory bowel disease activity and thiopurine therapy on birth weight: A meta-analysis
  Begoña Gonzalez-Suarez, Shreyashee Sengupta, Alan C Moss
  World Journal of Gastroenterology.2017; 23(45): 8082.     CrossRef
• Maternal and fetal outcomes in pregnant Japanese women with inflammatory bowel disease: our experience with a series of 23 cases
  Naoki Minami, Minoru Matsuura, Yorimitsu Koshikawa, Satoshi Yamada, Yusuke Honzawa, Shuji Yamamoto, Hiroshi Nakase
  Intestinal Research.2017; 15(1): 90.     CrossRef
• Concerns in pregnancy and childbirth of women with inflammatory bowel disease
  Sung-Ae Jung
  Intestinal Research.2016; 14(2): 107.     CrossRef
• Common Adverse Effects of Anti-TNF Agents on Gestation
  Zacharias Fasoulakis, Panagiotis Antsaklis, Nikolaos Galanopoulos, Emmanuel Kontomanolis
  Obstetrics and Gynecology International.2016; 2016: 1.     CrossRef